72 Investment Holdings, LLC
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), 72 Investment Holdings, LLC reported 7 stock positions worth $46.5 million. Its top holding was Lenz Therapeutics (LENZ) at 51.9% of the portfolio, followed by Korro Bio (KRRO, 19.9%) and Alto Neuroscience (ANRO, 16.4%). Its holdings were unchanged from Q2 2024.
- Most Recent 13F
- Q2 2026
- Location
- STAMFORD, CT
- CIK
- 0001832749
- Portfolio Value
- $46.5M (Q3 2024)
- SEC Filing
- 0000902664-24-006613 ↗ filed Nov 14, 2024
Holdings Value
Holdings 7 stocks · $46.5M
| LENZ Lenz Therapeutics Inc. | 51.95% | 1,017,751 | $24.2M | No change |
| KRRO Korro Bio Inc. | 19.89% | 276,831 | $9.3M | No change |
| ANRO Alto Neuroscience Inc. | 16.42% | 667,778 | $7.6M | No change |
| PRAX Praxis Precision Medicines I | 8.16% | 65,933 | $3.8M | No change |
| CRBU Caribou Biosciences Inc. | 2.00% | 474,067 | $929K | No change |
| OMGAQ Omega Therapeutics Inc. | 0.93% | 352,941 | $431K | No change |
| TSBX Turnstone Biologics Corp. | 0.66% | 549,980 | $306K | No change |
Portfolio Sells Q2 2024 → Q3 2024
| None this quarter. | |||
Portfolio Buys Q2 2024 → Q3 2024
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 5 | $50.0M | PRAX, ANRO, LENZ, KRRO, CRBU |
| Q1 2026 | 5 | $49.6M | PRAX, ANRO, LENZ, KRRO, CRBU |
| Q4 2025 | 5 | $50.6M | PRAX, LENZ, ANRO, KRRO, CRBU |
| Q3 2025 | 5 | $67.9M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q2 2025 | 6 | $38.3M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q1 2025 | 6 | $35.6M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q4 2024 | 7 | $49.1M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q3 2024 | 7 | $46.5M | LENZ, KRRO, ANRO, PRAX, CRBU |
| Q2 2024 | 7 | $39.8M | LENZ, KRRO, ANRO, PRAX, TSBX |
| Q1 2024 | 7 | $67.1M | KRRO, LENZ, ANRO, PRAX, CRBU |